Qualitative assessment of anti‐SARS‐CoV‐2 spike protein immunogenicity (QUASI) after COVID‐19 vaccination in older people living with HIV

OBJECTIVES: Effective and safe COVID‐19 vaccines have been developed and have resulted in decreased incidence and severity of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and can decrease secondary transmission. However, there are concerns about dampened immune responses to...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuan, Jessica J., Zapata, Heidi, Critch‐Gilfillan, Terese, Ryall, Linda, Turcotte, Barbara, Mutic, Suzana, Andrews, Laurie, Roh, Michelle E., Friedland, Gerald, Barakat, Lydia, Ogbuagu, Onyema
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652674/
https://www.ncbi.nlm.nih.gov/pubmed/34632695
http://dx.doi.org/10.1111/hiv.13188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652674/
https://www.ncbi.nlm.nih.gov/pubmed/34632695
http://dx.doi.org/10.1111/hiv.13188

Ejemplares similares